Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I - PubMed (original) (raw)
. 2005 May;19(5):1304-17.
doi: 10.1210/me.2004-0239. Epub 2005 Feb 3.
Affiliations
- PMID: 15695372
- DOI: 10.1210/me.2004-0239
Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I
Caroline Treins et al. Mol Endocrinol. 2005 May.
Abstract
Hypoxia-inducible factor-1 (HIF-1), a transcription factor composed of two subunits (HIF-1alpha and HIF-1beta), initially described as a mediator of adaptive responses to changes in tissue oxygenation, has been shown to be activated in an oxygen-independent manner. In this report, we studied the action of IGF-I on the regulation of HIF-1 in human retinal epithelial cells. We show that IGF-I stimulates HIF-1alpha accumulation, HIF-1alpha nuclear translocation, and HIF-1 activity by regulation of HIF-1alpha expression through a posttranscriptional mechanism. In addition, we demonstrate that IGF-I stimulates HIF-1 activity through phosphatidylinositol-3-kinase/ mammalian target of rapamycin and MAPK-dependent signaling pathways leading to VEGF (vascular endothelial growth factor) mRNA expression. Three human prolyl-hydroxylases PHD-1, -2, and -3 (PHD-containing protein) and an asparaginyl-hydroxylase factor inhibiting HIF-1, which regulate HIF-1alpha stability and HIF-1 activity in response to hypoxia, have been described. Our analysis of their mRNA expression showed a different magnitude and time course of expression pattern in response to insulin and IGF-I compared with CoCl(2). Taken together, our data reveal that growth factors and CoCl(2), which mimics hypoxia, lead to HIF-1 activation and ensuing VEGF expression by different mechanisms. Their joined actions are likely to lead to an important and sustained increase in VEGF action on retinal blood vessels, and hence to have devastating effects on the development of diabetic retinopathy.
Similar articles
- Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Poulaki V, et al. J Clin Invest. 2002 Mar;109(6):805-15. doi: 10.1172/JCI13776. J Clin Invest. 2002. PMID: 11901189 Free PMC article. - Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway.
Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E. Treins C, et al. J Biol Chem. 2002 Aug 2;277(31):27975-81. doi: 10.1074/jbc.M204152200. Epub 2002 May 24. J Biol Chem. 2002. PMID: 12032158 - trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z, Fang J, Xia C, Shi X, Jiang BH. Cao Z, et al. Clin Cancer Res. 2004 Aug 1;10(15):5253-63. doi: 10.1158/1078-0432.CCR-03-0588. Clin Cancer Res. 2004. PMID: 15297429 - HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases.
Michiels C, Minet E, Michel G, Mottet D, Piret JP, Raes M. Michiels C, et al. IUBMB Life. 2001 Jul;52(1-2):49-53. doi: 10.1080/15216540252774766. IUBMB Life. 2001. PMID: 11795593 Review. - Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions.
Hellwig-Bürgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W. Hellwig-Bürgel T, et al. J Interferon Cytokine Res. 2005 Jun;25(6):297-310. doi: 10.1089/jir.2005.25.297. J Interferon Cytokine Res. 2005. PMID: 15957953 Review.
Cited by
- Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway.
Eliasz S, Liang S, Chen Y, De Marco MA, Machek O, Skucha S, Miele L, Bocchetta M. Eliasz S, et al. Oncogene. 2010 Apr 29;29(17):2488-98. doi: 10.1038/onc.2010.7. Epub 2010 Feb 15. Oncogene. 2010. PMID: 20154720 Free PMC article. - Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.
Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M. Spirli C, et al. Hepatology. 2010 May;51(5):1778-88. doi: 10.1002/hep.23511. Hepatology. 2010. PMID: 20131403 Free PMC article. - IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis.
Zhang C, Lu L, Li Y, Wang X, Zhou J, Liu Y, Fu P, Gallicchio MA, Bach LA, Duan C. Zhang C, et al. Int J Cancer. 2012 May 1;130(9):2003-12. doi: 10.1002/ijc.26201. Epub 2011 Aug 5. Int J Cancer. 2012. PMID: 21618524 Free PMC article. - Interferon-α enhances the susceptibility of renal cell carcinoma to rapamycin by suppressing mTOR activity.
Han X, Shang D, Han T, Xu X, Tian Y. Han X, et al. Exp Ther Med. 2014 Jul;8(1):267-273. doi: 10.3892/etm.2014.1691. Epub 2014 Apr 25. Exp Ther Med. 2014. PMID: 24944633 Free PMC article. - Involvement of hypoxia-inducing factor-1alpha-dependent plasminogen activator inhibitor-1 up-regulation in Cyr61/CCN1-induced gastric cancer cell invasion.
Lin MT, Kuo IH, Chang CC, Chu CY, Chen HY, Lin BR, Sureshbabu M, Shih HJ, Kuo ML. Lin MT, et al. J Biol Chem. 2008 Jun 6;283(23):15807-15. doi: 10.1074/jbc.M708933200. Epub 2008 Apr 1. J Biol Chem. 2008. PMID: 18381294 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous